SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Centenial Surgical Suture Ltd

BSE: 531380 NSE: ISIN: INE405H01018
  |   Sector:  Healthcare   |   Industry:  Medical Equipment/Supplies/Accessories

Snapshot

Q.1 Which industry/sub-sector does Centenial Surgical Suture Ltd belong to?
Centenial Surgical Suture Ltd belongs to the Healthcare sector, operating specifically within the Medical Equipment/Supplies/Accessories segment.
Q.2 Is Centenial Surgical Suture Ltd a good quality company?
Centenial Surgical Suture Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Centenial Surgical Suture Ltd undervalued or overvalued?
Centenial Surgical Suture Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Centenial Surgical Suture Ltd a good buy now?
Centenial Surgical Suture Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd revenue growth is 4.6% for FY-2025 , which is above its 5 year CAGR of -0.8% , indicating faster growth.
Q.2 Gross Profit margin of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd Gross profit margin which is the profit after deduction of direct costs, is 4.9% for FY-2025 , which is below its 5 year median of 5.3% , indicating decreasing margins.
Q.3 Operating Profit Margin of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 11.99% for FY-2025 , which is above its 5 year median of 10.09% indicating increasing margins.
Q.4 Net Profit Margin of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd Net Profit Margin is -2.73% for FY-2025 , is below with its 5 year median of 1.68%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 4.9 5.3
Operating Profit Margin 11.99 10.09
Net Profit Margin -2.73 1.68
Q.5 Return on Asset of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd Return on Asset is -1.79%, which is below its 5 year historical median of 1.38%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd Return on equity is -4.93% for FY-2025 , which is below its historical median of 3.07%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd Return on capital employed is 5.09% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd Cash conversion cycle is 338 days, below its historical median of 338 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.65 0.68
ROE -4.93 3.07
ROCE 5.09 8.02
Cash Conversion Cycle 338 days 338 days
Q.9 Debt to Equity ratio of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd Debt-to-Equity ratio is 0.40 , which is above with the industry average of 0.36 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Centenial Surgical Suture Ltd?
Centenial Surgical Suture Ltd Debt to cash flow from operations is 0.72 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Centenial Surgical Suture Ltd?
Promoters hold 46.89% of the Centenial Surgical Suture Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Centenial Surgical Suture Ltd vs industry peers?
Centenial Surgical Suture Ltd revenue CAGR is -0.76% , compared to the industry median CAGR of 1.45% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 53.5 36.5
Gross Profit 2.6 4.1
Operating Profit 6.4 3.3
Net Profit -1.5 2.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.65 0.73
ROE -4.93 15.79
ROCE 5.09 20.14
Cash Conversion Cycle (days) 338.22 86

Valuation & price assessment

Q.1 Stock return of Centenial Surgical Suture Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 1.4% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 1.4% 20.2% 16.4% -25.4%
Q.3 Valuation ratios of Centenial Surgical Suture Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings - 32.81 148.25
Price to Book 1.2 0.73 3.50
Price to Sales 0.64 0.47 3.36
EV to EBITDA 7.08 7.04 19.40

Check more companies

1. Poly Medicure
2. 3B Blackbio Dx
3. Osel Devices
4. Laxmi Denta
5. Prevest Denpro
6. Hemant Surgical Inds
7. Yash Optics & Lens
8. Nureca Ltd.
9. Earkart
10. Raaj Medisafe India
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×